125 related articles for article (PubMed ID: 32590454)
41. Prognostic significance of terminal deoxynucleotidyl transferase activity in acute nonlymphoblastic leukemia.
Benedetto P; Mertelsmann R; Szatrowski TH; Andreeff M; Gee T; Arlin Z; Kempin S; Clarkson B
J Clin Oncol; 1986 Apr; 4(4):489-95. PubMed ID: 3958762
[TBL] [Abstract][Full Text] [Related]
42. Terminal deoxynucleotidyl transferase in non-Hodgkin's lymphoma.
Braziel RM; Keneklis T; Donlon JA; Hsu SM; Cossman J; Bollum FJ; Jaffe ES
Am J Clin Pathol; 1983 Nov; 80(5):655-9. PubMed ID: 6356870
[TBL] [Abstract][Full Text] [Related]
43. Development of an optimal protocol for antigen retrieval: a 'test battery' approach exemplified with reference to the staining of retinoblastoma protein (pRB) in formalin-fixed paraffin sections.
Shi SR; Cote RJ; Yang C; Chen C; Xu HJ; Benedict WF; Taylor CR
J Pathol; 1996 Jul; 179(3):347-52. PubMed ID: 8774494
[TBL] [Abstract][Full Text] [Related]
44. Terminal deoxynucleotidyl transferase in acute leukemias by direct immunofluorescence.
Nair CN; Gothoskar BP; Gladstone B; Badrinath Y; Chhajlani V; Karnik M; Nerurkar A; Damle SR; Redkar SL; Gopal R
Neoplasma; 1987; 34(3):305-11. PubMed ID: 3302737
[TBL] [Abstract][Full Text] [Related]
45. Combined flow cytometric assessment of cell surface antigens and nuclear TdT for the detection of minimal residual disease in acute leukaemia.
Drach J; Gattringer C; Huber H
Br J Haematol; 1991 Jan; 77(1):37-42. PubMed ID: 1998595
[TBL] [Abstract][Full Text] [Related]
46. Ultrastructural demonstration of terminal deoxynucleotidyl transferase (TdT).
Steinmann G; Mertelsmann R; deHarven E; Moore MA
Blood; 1981 Feb; 57(2):368-71. PubMed ID: 7004538
[TBL] [Abstract][Full Text] [Related]
47. Myeloblastic and lymphoblastic markers in acute undifferentiated leukemia and chronic myelogenous leukemia in blast crisis.
Shumak KH; Baker MA; Taub RN; Coleman MS
Cancer Res; 1980 Nov; 40(11):4048-52. PubMed ID: 6937237
[TBL] [Abstract][Full Text] [Related]
48. Unique pattern of nuclear TdT immunofluorescence distinguishes normal precursor B cells (Hematogones) from lymphoblasts of precursor B-lymphoblastic leukemia.
Hurford MT; Altman AJ; DiGiuseppe JA; Sherburne BJ; Rezuke WN
Am J Clin Pathol; 2008 May; 129(5):700-5. PubMed ID: 18426728
[TBL] [Abstract][Full Text] [Related]
49. The value of anti-pax-5 immunostaining in routinely fixed and paraffin-embedded sections: a novel pan pre-B and B-cell marker.
Torlakovic E; Torlakovic G; Nguyen PL; Brunning RD; Delabie J
Am J Surg Pathol; 2002 Oct; 26(10):1343-50. PubMed ID: 12360049
[TBL] [Abstract][Full Text] [Related]
50. Recombination activating gene-1 (RAG-1) expression in all differentiation stages of B-lineage precursor acute lymphoblastic leukemia.
Umiel T; Pattengale P; Weinberg K
Leukemia; 1993 Mar; 7(3):435-40. PubMed ID: 8445948
[TBL] [Abstract][Full Text] [Related]
51. Terminal deoxynucleotidyl transferase activity in thymocytes of kittens.
Richerson JT; Coleman MS; Brunner CJ; Mattingly SF
Am J Vet Res; 1985 Dec; 46(12):2616-8. PubMed ID: 3841264
[TBL] [Abstract][Full Text] [Related]
52. Lymphoblastic lymphoma expressing natural killer cell phenotype with involvement of the mediastinum and nasal cavity.
Koita H; Suzumiya J; Ohshima K; Takeshita M; Kimura N; Kikuchi M; Koono M
Am J Surg Pathol; 1997 Feb; 21(2):242-8. PubMed ID: 9042293
[TBL] [Abstract][Full Text] [Related]
53. Terminal deoxynucleotidyl transferase expression can precede T cell receptor beta chain and gamma chain rearrangement in T cell acute lymphoblastic leukemia.
Greenberg JM; Kersey JH
Blood; 1987 Jan; 69(1):356-60. PubMed ID: 3491642
[TBL] [Abstract][Full Text] [Related]
54. The prognostic significance of terminal deoxynucleotidyl transferase (TDT) in patients with leukemias and malignant lymphomas.
Mertelsmann R
Adv Exp Med Biol; 1982; 145():259-77. PubMed ID: 7051779
[No Abstract] [Full Text] [Related]
55. Burkitt Lymphoma With Aberrant Expression of Cytoplasmic Terminal Deoxynucleotidyl Transferase: A Case Report.
Cunningham MT; Winters C; Farrell D
Cureus; 2024 Feb; 16(2):e53972. PubMed ID: 38348200
[TBL] [Abstract][Full Text] [Related]
56. Comparison of the expression of terminal deoxynucleotidyl transferase and common acute lymphoblastic leukemia antigen in selected hematologic malignancies.
Bodner SM; Casavant CH; McHugh TM; Stites DP
Diagn Immunol; 1985; 3(3):139-44. PubMed ID: 2932276
[TBL] [Abstract][Full Text] [Related]
57. Human bone marrow cells positive for terminal deoxynucleotidyl transferase (TdT), HLA-DR, and a T cell marker may represent prothymocytes.
van Dongen JJ; Hooijkaas H; Comans-Bitter M; Hählen K; de Klein A; van Zanen GE; van't Veer MB; Abels J; Benner R
J Immunol; 1985 Nov; 135(5):3144-50. PubMed ID: 2413114
[TBL] [Abstract][Full Text] [Related]
58. [Lymphoblastic lymphoma and acute lymphoblastic leukemia: a clinicopathologic, immunophenotypic and prognostic study in 153 Chinese patients].
Pan Y; Li GD; Liu WP; Zhang WY; Tang Y; Li FY
Zhonghua Bing Li Xue Za Zhi; 2009 Dec; 38(12):810-5. PubMed ID: 20193455
[TBL] [Abstract][Full Text] [Related]
59. Terminal deoxynucleotidyl transferase positive lymphoblastic lymphoma: a study of 15 cases.
Long JC; McCaffrey RP; Aisenberg AC; Marks SM; Kung PC
Cancer; 1979 Dec; 44(6):2127-39. PubMed ID: 315816
[TBL] [Abstract][Full Text] [Related]
60. Differential expression of terminal transferase (TdT) in acute lymphocytic leukaemia expressing myeloid antigens and TdT positive acute myeloid leukaemia as compared to myeloid antigen negative acute lymphocytic leukaemia.
Paietta E; Racevskis J; Bennett JM; Wiernik PH
Br J Haematol; 1993 Jul; 84(3):416-22. PubMed ID: 8217792
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
